(Q44171806)

30 November 2017

title

HIV requires multiple gp120 molecules for CD4-mediated infection (English)

1 reference

30 November 2017

Layne SP

1

1 reference

30 November 2017

Merges MJ

2

1 reference

30 November 2017

Dembo M

3

1 reference

30 November 2017

Spouge JL

4

1 reference

30 November 2017

Nara PL

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 July 1990

1 reference

30 November 2017

1 reference

30 November 2017

volume

346

1 reference

30 November 2017

issue

6281

1 reference

30 November 2017

page(s)

277-279

1 reference

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

30 November 2017

cites work

1 reference

7 January 2021

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

7 January 2021

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule

1 reference

7 January 2021

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

1 reference

7 January 2021

Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.

1 reference

7 January 2021

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

7 January 2021

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

7 January 2021

HIV infection is blocked in vitro by recombinant soluble CD4.

1 reference

7 January 2021

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

1 reference

7 January 2021

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

7 January 2021

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

1 reference

7 January 2021

Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.

1 reference

7 January 2021

Designing CD4 immunoadhesins for AIDS therapy

1 reference

7 January 2021

Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.

1 reference

7 January 2021

CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle

1 reference

7 January 2021

Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques

1 reference

7 January 2021

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial

1 reference

7 January 2021

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

1 reference

7 January 2021

Quantifying the infectivity of human immunodeficiency virus

1 reference

7 January 2021

Analytic results for quantifying HIV infectivity

1 reference

7 January 2021

Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody

1 reference

7 January 2021

Quantitative infectivity assay for HIV-1 and-2.

1 reference

7 January 2021

Neutralization of poliovirus by a monoclonal antibody: Kinetics and stoichiometry

1 reference

7 January 2021

Quantitative relationships between an influenza virus and neutralizing antibody

1 reference

7 January 2021

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

1 reference

7 January 2021

Extensive variation of human immunodeficiency virus type-1 in vivo

1 reference

7 January 2021

Single amino-acid changes in HIV envelope affect viral tropism and receptor binding

1 reference

7 January 2021

Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIB.

1 reference

7 January 2021

The organization of the envelope projections on the surface of HIV

1 reference

7 January 2021

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

7 January 2021

Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells

1 reference

7 January 2021

Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy

1 reference

7 January 2021

Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4

1 reference

7 January 2021

Identifiers

DOI

10.1038/346277A0

1 reference

Dimensions Publication ID

30 November 2017

1011883264

0 references

1 reference